Aline Andres
Concepts (342)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Milk, Human | 19 | 2024 | 102 | 5.630 |
Why?
| Body Composition | 17 | 2024 | 326 | 4.710 |
Why?
| Breast Feeding | 25 | 2024 | 189 | 4.130 |
Why?
| Obesity | 28 | 2024 | 1112 | 3.940 |
Why?
| Adiposity | 10 | 2024 | 132 | 3.770 |
Why?
| Body Mass Index | 22 | 2024 | 658 | 3.450 |
Why?
| Pregnancy | 45 | 2025 | 2609 | 3.290 |
Why?
| Weight Gain | 13 | 2023 | 234 | 3.050 |
Why?
| Overweight | 11 | 2024 | 215 | 2.680 |
Why?
| Exercise | 10 | 2024 | 504 | 2.590 |
Why?
| Mothers | 8 | 2024 | 256 | 2.490 |
Why?
| Infant Formula | 19 | 2024 | 145 | 2.330 |
Why?
| Adipose Tissue | 7 | 2024 | 191 | 2.260 |
Why?
| Infant | 39 | 2024 | 3584 | 2.010 |
Why?
| Child Development | 9 | 2021 | 193 | 1.990 |
Why?
| Maternal Nutritional Physiological Phenomena | 6 | 2021 | 55 | 1.980 |
Why?
| Female | 82 | 2025 | 26829 | 1.960 |
Why?
| Oligosaccharides | 5 | 2024 | 35 | 1.720 |
Why?
| Breast Milk Expression | 2 | 2023 | 4 | 1.710 |
Why?
| Milk | 9 | 2023 | 79 | 1.700 |
Why?
| Pregnancy Complications | 10 | 2023 | 381 | 1.650 |
Why?
| Longitudinal Studies | 17 | 2024 | 700 | 1.550 |
Why?
| Absorptiometry, Photon | 7 | 2023 | 155 | 1.530 |
Why?
| Insulin Resistance | 8 | 2021 | 260 | 1.470 |
Why?
| Humans | 90 | 2025 | 50201 | 1.450 |
Why?
| Plethysmography | 5 | 2020 | 43 | 1.400 |
Why?
| Placenta | 4 | 2025 | 135 | 1.340 |
Why?
| Diet | 14 | 2024 | 554 | 1.270 |
Why?
| Follicular Fluid | 2 | 2019 | 9 | 1.220 |
Why?
| Cohort Studies | 14 | 2024 | 1414 | 1.190 |
Why?
| Pregnant Women | 5 | 2022 | 76 | 1.190 |
Why?
| Child, Preschool | 17 | 2024 | 3896 | 1.190 |
Why?
| Infant Nutritional Physiological Phenomena | 7 | 2023 | 55 | 1.170 |
Why?
| Fluorocarbons | 2 | 2025 | 51 | 1.170 |
Why?
| Infant Food | 3 | 2020 | 28 | 1.160 |
Why?
| Bottle Feeding | 5 | 2020 | 34 | 1.150 |
Why?
| Infant, Newborn | 22 | 2024 | 2770 | 1.090 |
Why?
| Postpartum Period | 4 | 2023 | 110 | 1.050 |
Why?
| Isoleucine | 2 | 2024 | 26 | 1.010 |
Why?
| Adult | 30 | 2025 | 13486 | 1.000 |
Why?
| Anthropometry | 6 | 2024 | 92 | 0.980 |
Why?
| Magnetic Resonance Spectroscopy | 2 | 2020 | 246 | 0.960 |
Why?
| DNA Methylation | 3 | 2025 | 546 | 0.950 |
Why?
| Metabolome | 3 | 2020 | 92 | 0.930 |
Why?
| Child | 17 | 2024 | 6862 | 0.910 |
Why?
| Male | 38 | 2025 | 25572 | 0.880 |
Why?
| Lipid Metabolism | 4 | 2019 | 176 | 0.850 |
Why?
| Growth | 3 | 2020 | 40 | 0.840 |
Why?
| Eating | 2 | 2021 | 158 | 0.830 |
Why?
| Blood Glucose | 3 | 2020 | 434 | 0.820 |
Why?
| Prenatal Care | 3 | 2023 | 108 | 0.820 |
Why?
| Sleep | 1 | 2023 | 179 | 0.790 |
Why?
| Pregnancy Trimester, First | 2 | 2023 | 22 | 0.770 |
Why?
| Homeostasis | 2 | 2020 | 203 | 0.750 |
Why?
| Leptin | 3 | 2022 | 143 | 0.730 |
Why?
| Monosaccharides | 1 | 2020 | 7 | 0.730 |
Why?
| Dietary Proteins | 2 | 2020 | 243 | 0.710 |
Why?
| Parents | 2 | 2022 | 320 | 0.700 |
Why?
| Pregnancy Trimester, Third | 1 | 2020 | 63 | 0.700 |
Why?
| Maternal-Fetal Exchange | 1 | 2020 | 43 | 0.690 |
Why?
| Isoflavones | 4 | 2009 | 87 | 0.690 |
Why?
| Early Growth Response Protein 1 | 3 | 2016 | 33 | 0.660 |
Why?
| Body Weight | 3 | 2021 | 513 | 0.660 |
Why?
| Fertilization in Vitro | 1 | 2019 | 28 | 0.640 |
Why?
| Lactation | 4 | 2023 | 59 | 0.610 |
Why?
| Soy Milk | 6 | 2018 | 37 | 0.600 |
Why?
| Oocytes | 1 | 2017 | 73 | 0.550 |
Why?
| Antioxidants | 1 | 2019 | 237 | 0.550 |
Why?
| Directive Counseling | 1 | 2017 | 23 | 0.550 |
Why?
| Ovary | 2 | 2016 | 114 | 0.540 |
Why?
| C-Reactive Protein | 1 | 2017 | 143 | 0.530 |
Why?
| Triglycerides | 1 | 2017 | 153 | 0.530 |
Why?
| Prenatal Diagnosis | 1 | 2016 | 108 | 0.520 |
Why?
| Body Water | 2 | 2012 | 24 | 0.510 |
Why?
| Patient Compliance | 1 | 2017 | 230 | 0.500 |
Why?
| Sexual Development | 1 | 2015 | 6 | 0.490 |
Why?
| Genitalia, Male | 1 | 2015 | 13 | 0.490 |
Why?
| Soybean Proteins | 4 | 2020 | 160 | 0.490 |
Why?
| Behavior Therapy | 1 | 2017 | 180 | 0.490 |
Why?
| Soy Foods | 1 | 2015 | 20 | 0.490 |
Why?
| Genitalia, Female | 1 | 2015 | 18 | 0.490 |
Why?
| Child of Impaired Parents | 1 | 2015 | 41 | 0.480 |
Why?
| Gestational Age | 5 | 2025 | 422 | 0.480 |
Why?
| Risk Factors | 6 | 2024 | 3644 | 0.480 |
Why?
| Oxidative Stress | 1 | 2019 | 763 | 0.460 |
Why?
| Maternal Exposure | 3 | 2025 | 91 | 0.440 |
Why?
| Animals | 18 | 2024 | 13141 | 0.440 |
Why?
| Feces | 3 | 2024 | 131 | 0.430 |
Why?
| Infant Behavior | 1 | 2012 | 18 | 0.400 |
Why?
| Bone Density | 2 | 2023 | 386 | 0.400 |
Why?
| Young Adult | 8 | 2025 | 4052 | 0.380 |
Why?
| Case-Control Studies | 4 | 2019 | 1145 | 0.380 |
Why?
| RNA, Ribosomal, 16S | 4 | 2024 | 111 | 0.370 |
Why?
| Military Personnel | 2 | 2023 | 165 | 0.370 |
Why?
| Umbilical Cord | 3 | 2017 | 35 | 0.360 |
Why?
| Insulin | 4 | 2022 | 460 | 0.360 |
Why?
| Cross-Sectional Studies | 3 | 2024 | 1580 | 0.350 |
Why?
| Feeding Behavior | 2 | 2024 | 177 | 0.350 |
Why?
| Food Supply | 2 | 2023 | 90 | 0.350 |
Why?
| Phenotype | 3 | 2023 | 732 | 0.340 |
Why?
| Linear Models | 2 | 2021 | 279 | 0.340 |
Why?
| Magnetic Resonance Imaging | 3 | 2020 | 1529 | 0.330 |
Why?
| Viruses | 1 | 2009 | 21 | 0.330 |
Why?
| Virus Diseases | 1 | 2009 | 39 | 0.320 |
Why?
| Rotavirus | 2 | 2009 | 9 | 0.310 |
Why?
| Antiviral Agents | 1 | 2009 | 168 | 0.300 |
Why?
| Speech Perception | 3 | 2016 | 90 | 0.300 |
Why?
| Inflammation | 3 | 2017 | 608 | 0.290 |
Why?
| Breast | 2 | 2023 | 86 | 0.280 |
Why?
| Environmental Pollutants | 2 | 2025 | 94 | 0.280 |
Why?
| Birth Weight | 3 | 2025 | 121 | 0.280 |
Why?
| Interleukin-8 | 2 | 2024 | 86 | 0.250 |
Why?
| Diffusion Tensor Imaging | 3 | 2023 | 92 | 0.240 |
Why?
| Heart | 2 | 2020 | 336 | 0.240 |
Why?
| Temperament | 1 | 2024 | 22 | 0.240 |
Why?
| Fathers | 1 | 2024 | 24 | 0.230 |
Why?
| Vagus Nerve | 2 | 2015 | 22 | 0.230 |
Why?
| Arkansas | 4 | 2020 | 1988 | 0.230 |
Why?
| Prospective Studies | 5 | 2023 | 2396 | 0.220 |
Why?
| Fast Foods | 1 | 2023 | 9 | 0.220 |
Why?
| Evoked Potentials | 2 | 2016 | 72 | 0.220 |
Why?
| Sodium, Dietary | 1 | 2023 | 23 | 0.220 |
Why?
| Amino Acids, Branched-Chain | 2 | 2021 | 39 | 0.210 |
Why?
| Sex Factors | 5 | 2025 | 700 | 0.210 |
Why?
| Matrix Attachment Region Binding Proteins | 1 | 2023 | 35 | 0.210 |
Why?
| Immunity, Innate | 1 | 2024 | 105 | 0.210 |
Why?
| Intention | 1 | 2023 | 43 | 0.210 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 73 | 0.210 |
Why?
| Hypersensitivity | 1 | 2023 | 75 | 0.210 |
Why?
| Accelerometry | 1 | 2022 | 10 | 0.210 |
Why?
| Metabolomics | 2 | 2020 | 133 | 0.210 |
Why?
| Diet, High-Fat | 3 | 2020 | 214 | 0.210 |
Why?
| Follow-Up Studies | 3 | 2019 | 2188 | 0.200 |
Why?
| Educational Status | 1 | 2023 | 225 | 0.200 |
Why?
| Lipids | 1 | 2022 | 147 | 0.200 |
Why?
| Immunoglobulin A | 1 | 2021 | 45 | 0.200 |
Why?
| Depressive Disorder, Major | 1 | 2023 | 150 | 0.190 |
Why?
| Metabolic Networks and Pathways | 2 | 2019 | 92 | 0.190 |
Why?
| Antibodies, Viral | 1 | 2021 | 94 | 0.190 |
Why?
| Epigenesis, Genetic | 1 | 2025 | 371 | 0.190 |
Why?
| Leucine | 1 | 2021 | 118 | 0.190 |
Why?
| Predictive Value of Tests | 2 | 2016 | 921 | 0.180 |
Why?
| Urinalysis | 1 | 2020 | 32 | 0.180 |
Why?
| Cattle | 3 | 2020 | 208 | 0.180 |
Why?
| Body Fat Distribution | 1 | 2020 | 9 | 0.180 |
Why?
| Adolescent | 3 | 2019 | 6459 | 0.180 |
Why?
| Models, Biological | 2 | 2020 | 722 | 0.180 |
Why?
| Brain | 6 | 2023 | 1311 | 0.180 |
Why?
| Body Weights and Measures | 1 | 2020 | 17 | 0.180 |
Why?
| Physical Conditioning, Animal | 1 | 2020 | 54 | 0.170 |
Why?
| Health Status | 2 | 2020 | 299 | 0.170 |
Why?
| Health Behavior | 1 | 2022 | 250 | 0.170 |
Why?
| Transcriptome | 3 | 2018 | 316 | 0.170 |
Why?
| Exercise Therapy | 1 | 2020 | 94 | 0.170 |
Why?
| Insulin-Like Growth Factor I | 1 | 2019 | 138 | 0.160 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2020 | 326 | 0.160 |
Why?
| Cardiovascular Diseases | 1 | 2024 | 449 | 0.160 |
Why?
| Uric Acid | 1 | 2019 | 23 | 0.160 |
Why?
| Diabetes, Gestational | 1 | 2019 | 52 | 0.160 |
Why?
| GABAergic Neurons | 1 | 2018 | 10 | 0.160 |
Why?
| Feasibility Studies | 1 | 2020 | 383 | 0.160 |
Why?
| Purines | 1 | 2018 | 38 | 0.150 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 181 | 0.150 |
Why?
| Exosomes | 1 | 2018 | 47 | 0.150 |
Why?
| Pilot Projects | 1 | 2020 | 703 | 0.150 |
Why?
| Adipogenesis | 2 | 2016 | 49 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 579 | 0.150 |
Why?
| Oocyte Retrieval | 1 | 2017 | 5 | 0.140 |
Why?
| Chemokine CXCL2 | 1 | 2017 | 11 | 0.140 |
Why?
| Ovulation Induction | 1 | 2017 | 10 | 0.140 |
Why?
| Inhibitor of Differentiation Proteins | 1 | 2017 | 6 | 0.140 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2020 | 553 | 0.140 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2017 | 9 | 0.140 |
Why?
| Fatty Liver | 1 | 2018 | 128 | 0.140 |
Why?
| Gene Expression Profiling | 3 | 2017 | 1029 | 0.140 |
Why?
| Parity | 1 | 2017 | 50 | 0.140 |
Why?
| Ideal Body Weight | 1 | 2017 | 6 | 0.140 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2016 | 388 | 0.140 |
Why?
| Friends | 1 | 2017 | 21 | 0.140 |
Why?
| Organ Size | 2 | 2015 | 223 | 0.140 |
Why?
| Single-Cell Analysis | 1 | 2017 | 63 | 0.140 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 88 | 0.140 |
Why?
| Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.140 |
Why?
| Chemokine CXCL11 | 1 | 2016 | 6 | 0.140 |
Why?
| Granulosa Cells | 1 | 2016 | 12 | 0.130 |
Why?
| Amino Acids | 1 | 2019 | 373 | 0.130 |
Why?
| Versicans | 1 | 2016 | 10 | 0.130 |
Why?
| Glucose Transporter Type 4 | 1 | 2016 | 23 | 0.130 |
Why?
| Chemokine CXCL10 | 1 | 2016 | 19 | 0.130 |
Why?
| Monosaccharide Transport Proteins | 1 | 2016 | 14 | 0.130 |
Why?
| Sex Characteristics | 2 | 2018 | 192 | 0.130 |
Why?
| Tissue Array Analysis | 1 | 2016 | 45 | 0.130 |
Why?
| Receptors, CCR2 | 1 | 2016 | 14 | 0.130 |
Why?
| Food, Formulated | 2 | 2023 | 42 | 0.130 |
Why?
| Immunoblotting | 1 | 2016 | 116 | 0.130 |
Why?
| Guidelines as Topic | 1 | 2017 | 110 | 0.130 |
Why?
| Chemokine CCL2 | 1 | 2016 | 67 | 0.130 |
Why?
| RNA, Messenger | 2 | 2016 | 1097 | 0.130 |
Why?
| Phosphoproteins | 1 | 2016 | 111 | 0.130 |
Why?
| Rats, Sprague-Dawley | 2 | 2016 | 1581 | 0.130 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 155 | 0.130 |
Why?
| Nerve Tissue Proteins | 1 | 2017 | 191 | 0.130 |
Why?
| Carrier Proteins | 1 | 2017 | 302 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 139 | 0.130 |
Why?
| Family | 1 | 2017 | 177 | 0.130 |
Why?
| Cerebral Cortex | 1 | 2016 | 195 | 0.130 |
Why?
| Tissue Plasminogen Activator | 1 | 2016 | 110 | 0.120 |
Why?
| Ultrasonography | 2 | 2015 | 438 | 0.120 |
Why?
| Premature Birth | 1 | 2017 | 146 | 0.120 |
Why?
| Neoplasm Proteins | 1 | 2017 | 321 | 0.120 |
Why?
| MicroRNAs | 1 | 2018 | 349 | 0.120 |
Why?
| Up-Regulation | 1 | 2016 | 446 | 0.120 |
Why?
| Autonomic Nervous System | 1 | 2015 | 57 | 0.120 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 486 | 0.120 |
Why?
| Gene Expression Regulation | 2 | 2020 | 964 | 0.110 |
Why?
| Prognosis | 1 | 2019 | 1963 | 0.110 |
Why?
| Time Factors | 1 | 2020 | 2909 | 0.110 |
Why?
| Immunohistochemistry | 1 | 2016 | 973 | 0.110 |
Why?
| Deuterium Oxide | 1 | 2012 | 7 | 0.110 |
Why?
| Air | 1 | 2012 | 23 | 0.110 |
Why?
| Liver | 1 | 2018 | 1122 | 0.100 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 489 | 0.100 |
Why?
| Bacteria | 3 | 2022 | 220 | 0.100 |
Why?
| Life Style | 2 | 2023 | 140 | 0.100 |
Why?
| Disease Susceptibility | 1 | 2012 | 88 | 0.100 |
Why?
| Electroencephalography | 3 | 2023 | 303 | 0.100 |
Why?
| Mice, Inbred C57BL | 3 | 2024 | 1782 | 0.100 |
Why?
| Swine | 2 | 2010 | 408 | 0.100 |
Why?
| Cell Differentiation | 1 | 2014 | 648 | 0.090 |
Why?
| Evoked Potentials, Auditory | 1 | 2011 | 101 | 0.090 |
Why?
| Sensitivity and Specificity | 1 | 2012 | 871 | 0.090 |
Why?
| Mice | 4 | 2024 | 5673 | 0.090 |
Why?
| United States | 2 | 2020 | 4898 | 0.090 |
Why?
| Calibration | 1 | 2010 | 58 | 0.080 |
Why?
| Genitalia | 1 | 2009 | 11 | 0.080 |
Why?
| Radionuclide Imaging | 1 | 2010 | 116 | 0.080 |
Why?
| Phytoestrogens | 1 | 2009 | 22 | 0.080 |
Why?
| Anticarcinogenic Agents | 1 | 2009 | 32 | 0.080 |
Why?
| Flavonoids | 1 | 2009 | 39 | 0.080 |
Why?
| Genistein | 1 | 2009 | 46 | 0.080 |
Why?
| Biological Availability | 1 | 2009 | 99 | 0.080 |
Why?
| Cell Line | 2 | 2013 | 1010 | 0.080 |
Why?
| Species Specificity | 1 | 2009 | 191 | 0.080 |
Why?
| Reproducibility of Results | 1 | 2012 | 1195 | 0.080 |
Why?
| Gastrointestinal Tract | 1 | 2009 | 102 | 0.080 |
Why?
| Palmitates | 2 | 2022 | 29 | 0.080 |
Why?
| Gastrointestinal Diseases | 1 | 2009 | 128 | 0.080 |
Why?
| Rifabutin | 1 | 2007 | 5 | 0.070 |
Why?
| Lactams, Macrocyclic | 1 | 2007 | 14 | 0.070 |
Why?
| Benzoquinones | 1 | 2007 | 29 | 0.070 |
Why?
| Microscopy, Electron, Transmission | 1 | 2007 | 75 | 0.070 |
Why?
| Etoposide | 1 | 2007 | 71 | 0.070 |
Why?
| Analysis of Variance | 3 | 2014 | 563 | 0.070 |
Why?
| Estradiol | 1 | 2007 | 215 | 0.070 |
Why?
| Regression Analysis | 2 | 2017 | 395 | 0.060 |
Why?
| Placentation | 1 | 2025 | 12 | 0.060 |
Why?
| Bifidobacterium | 1 | 2024 | 7 | 0.060 |
Why?
| Mother-Child Relations | 1 | 2024 | 54 | 0.060 |
Why?
| Disease Models, Animal | 1 | 2009 | 1419 | 0.060 |
Why?
| Leukocytes, Mononuclear | 1 | 2024 | 113 | 0.060 |
Why?
| Language Development | 2 | 2016 | 28 | 0.060 |
Why?
| Immune System | 1 | 2024 | 43 | 0.060 |
Why?
| Food Handling | 1 | 2023 | 17 | 0.060 |
Why?
| Vitamins | 1 | 2023 | 63 | 0.050 |
Why?
| Alkaline Phosphatase | 1 | 2023 | 94 | 0.050 |
Why?
| Lymphocytes | 1 | 2024 | 154 | 0.050 |
Why?
| Osteocalcin | 1 | 2023 | 43 | 0.050 |
Why?
| Syndrome | 1 | 2023 | 239 | 0.050 |
Why?
| Nutritional Status | 1 | 2023 | 136 | 0.050 |
Why?
| Energy Intake | 1 | 2023 | 170 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2023 | 103 | 0.050 |
Why?
| Stress, Psychological | 1 | 2024 | 260 | 0.050 |
Why?
| Butyrates | 1 | 2022 | 31 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 28 | 0.050 |
Why?
| Gene Expression | 1 | 2024 | 612 | 0.050 |
Why?
| Carnitine | 1 | 2022 | 63 | 0.050 |
Why?
| Weight Loss | 1 | 2023 | 241 | 0.050 |
Why?
| Self Report | 1 | 2022 | 202 | 0.050 |
Why?
| RNA, Viral | 1 | 2021 | 124 | 0.050 |
Why?
| Phonetics | 2 | 2011 | 46 | 0.050 |
Why?
| Health Promotion | 1 | 2023 | 264 | 0.050 |
Why?
| Age Factors | 2 | 2014 | 1096 | 0.040 |
Why?
| Electric Impedance | 1 | 2020 | 42 | 0.040 |
Why?
| Optical Imaging | 1 | 2020 | 23 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 45 | 0.040 |
Why?
| Mental Disorders | 1 | 2024 | 400 | 0.040 |
Why?
| Transcription Factors | 1 | 2023 | 563 | 0.040 |
Why?
| Bone and Bones | 1 | 2023 | 477 | 0.040 |
Why?
| CpG Islands | 1 | 2020 | 106 | 0.040 |
Why?
| Language | 1 | 2020 | 134 | 0.040 |
Why?
| Energy Metabolism | 1 | 2022 | 284 | 0.040 |
Why?
| Biodiversity | 1 | 2018 | 40 | 0.040 |
Why?
| Metagenome | 1 | 2018 | 40 | 0.040 |
Why?
| Metagenomics | 1 | 2018 | 40 | 0.040 |
Why?
| Community-Based Participatory Research | 1 | 2020 | 197 | 0.040 |
Why?
| Depression | 1 | 2023 | 571 | 0.040 |
Why?
| Bile Acids and Salts | 1 | 2018 | 77 | 0.040 |
Why?
| Phylogeny | 1 | 2018 | 234 | 0.040 |
Why?
| RNA | 1 | 2018 | 166 | 0.040 |
Why?
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 8 | 0.040 |
Why?
| Mice, Knockout | 1 | 2020 | 840 | 0.040 |
Why?
| AMP-Activated Protein Kinases | 1 | 2017 | 28 | 0.040 |
Why?
| Myocardium | 1 | 2020 | 443 | 0.040 |
Why?
| Thinness | 1 | 2016 | 45 | 0.030 |
Why?
| Skull | 1 | 2016 | 77 | 0.030 |
Why?
| Thiazolidinediones | 1 | 2016 | 82 | 0.030 |
Why?
| Anisotropy | 1 | 2015 | 64 | 0.030 |
Why?
| Child Language | 1 | 2014 | 11 | 0.030 |
Why?
| Intelligence Tests | 1 | 2014 | 43 | 0.030 |
Why?
| Proteins | 1 | 2017 | 348 | 0.030 |
Why?
| Intelligence | 1 | 2014 | 59 | 0.030 |
Why?
| Glucose | 1 | 2016 | 339 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 61 | 0.030 |
Why?
| Culture Media | 1 | 2014 | 94 | 0.030 |
Why?
| Microarray Analysis | 1 | 2014 | 73 | 0.030 |
Why?
| DNA Primers | 1 | 2014 | 207 | 0.030 |
Why?
| Cell Adhesion Molecules | 1 | 2014 | 87 | 0.030 |
Why?
| Osteogenesis | 1 | 2016 | 353 | 0.030 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 90 | 0.030 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 125 | 0.030 |
Why?
| Activating Transcription Factor 3 | 1 | 2013 | 8 | 0.030 |
Why?
| Trophoblasts | 1 | 2013 | 29 | 0.030 |
Why?
| Serum Response Factor | 1 | 2013 | 40 | 0.030 |
Why?
| Genotype | 1 | 2014 | 542 | 0.030 |
Why?
| Neuropsychological Tests | 1 | 2014 | 337 | 0.030 |
Why?
| Blotting, Western | 1 | 2014 | 587 | 0.030 |
Why?
| Cells, Cultured | 1 | 2016 | 1587 | 0.030 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 118 | 0.030 |
Why?
| Cell Proliferation | 1 | 2016 | 987 | 0.030 |
Why?
| Interleukin-6 | 1 | 2013 | 266 | 0.020 |
Why?
| Milk Substitutes | 1 | 2010 | 5 | 0.020 |
Why?
| Speech Acoustics | 1 | 2010 | 18 | 0.020 |
Why?
| Rats | 1 | 2016 | 3277 | 0.020 |
Why?
| Diarrhea, Infantile | 1 | 2009 | 5 | 0.020 |
Why?
| Rotavirus Infections | 1 | 2009 | 6 | 0.020 |
Why?
| Single-Blind Method | 1 | 2009 | 114 | 0.020 |
Why?
| Signal Transduction | 1 | 2016 | 1612 | 0.020 |
Why?
| Testis | 1 | 2009 | 65 | 0.020 |
Why?
| Uterus | 1 | 2009 | 91 | 0.020 |
Why?
| Prostate | 1 | 2009 | 117 | 0.020 |
Why?
| Bone Development | 1 | 2009 | 64 | 0.020 |
Why?
| Animals, Newborn | 1 | 2009 | 367 | 0.020 |
Why?
|
|
Andres's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|